Zoster Vaccines; Risk of Guillain-Barré syndrome (GBS) following recombinant zoster vaccine(RZV); RZV risk-benefit analysis; Work group interpretation; Introduction of the Evidence to Recommendations Framework for use of RZV in immunocompromised adults.

Influenza Vaccines; Influenza surveillance update; Workgroup considerations

Comments on this video are allowed in accordance with our comment policy:

http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html

This video can also be viewed at

https://www.cdc.gov/vaccines/videos/low-res/acipfeb2021/ACIP-5_Zoster-Influenza_02-25-2021_LowRes.mp4